Gene | Hypermethylated CpGs/promoter region | Total CpGs/promoter | logFC | p Value | FDR | Detected in |
---|---|---|---|---|---|---|
KDR | 3 | 12 |  − 1.5 | 0.0000 | 0.0003 | Ex vivo and in vivo |
GCNT2 | 3 | 17 |  − 1.42 | 0.0000 | 0.0000 | Ex vivo |
CAPN13 | 3 | 6 |  − 1.39 | 0.0000 | 0.0000 | Ex vivo |
EYA4 | 7 | 51 |  − 1.37 | 0.0000 | 0.0013 | Ex vivo and in vivo |
ITGBL1 | 4 | 10 |  − 1.22 | 0.0001 | 0.0101 | Ex vivo |
SLC9A3 | 5 | 7 |  − 1.01 | 0.0001 | 0.0112 | Ex vivo |
CLIC6 | 5 | 11 |  − 0.89 | 0.0039 | 0.1244 | Ex vivo |
CHAD | 7 | 8 |  − 0.69 | 0.0312 | 0.4136 | Ex vivo |
SORBS2 | 7 | 55 |  − 0.69 | 0.0003 | 0.0201 | Ex vivo |
TAS1R1 | 3 | 14 |  − 0.68 | 0.0293 | 0.4018 | Ex vivo |
PSCA | 4 | 6 |  − 0.66 | 0.0266 | 0.3812 | Ex vivo |
CYP2E1 | 5 | 7 | 0.77 | 0.0063 | 0.1681 | Ex vivo |
TMEM176B | 2 | 20 | 0.89 | 0.0022 | 0.0838 | Ex vivo |
GJB2 | 3 | 20 | 1.05 | 0.0000 | 0.0021 | Ex vivo |
CDX2 | 2 | 12 | 1.34 | 0.0000 | 0.0033 | Ex vivo |